Ottawa Heart Institute Research Corporation: Acute Coronary Syndrome trials

The registry lists 10 Acute Coronary Syndrome studies with Ottawa Heart Institute Research Corporation as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 2 3Phase 3 3Phase 4 2No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Florbetaben for Imaging of Vascular AmyloidRecruitingNCT06091319
• The Safety and Efficacy Of Rivaroxaban and Ticagrelor for Patients With Atrial Fibrillation After Percutaneous Coronary InterventionCompletedNCT03331484Phase 3
• Milrinone Versus Dobutamine in Critically Ill PatientsCompletedNCT03207165Phase 4
• Timing of Coronary Artery Bypass Surgery Among Patients With Acute Coronary Syndromes Initially on TicagrelorCompletedNCT02668562Not applicable
• Transition From Ticagrelor to Clopidogrel Following Acute Coronary Syndrome: To Bolus or Not?CompletedNCT02054663Phase 4
• A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding RiskCompletedNCT02044146Phase 2/3
• Study to Develop a Non-invasive Marker for Monitoring Myocardial FibrosisTerminatedNCT01230918Phase 2
• ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic EvaluationCompletedNCT01184300Phase 2/3
• Using Automated Calls To Improve Compliance With Acute Coronary Syndrome Best Practice GuidelinesCompletedNCT01151800Not applicable
• Risk Stratification of Non ST Elevation ACS With Computed Tomographic Angiography (REACT)CompletedNCT00449826Not applicable